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Comparison of quantitative analysis to qualitative
analysis for interpretation of lower‑limb
lymphoscintigraphy
ABSTRACT
Qualitative analysis of lymphoscintigrams is subject to wide variability and may miss subtle differences in ilioinguinal uptake between
normal and abnormal limbs. This study compared quantitative analysis to qualitative analysis of lower‑limb lymphoscintigraphy in diagnosing
lymphedema. Fifty‑two lymphoscintigrams performed using standardized protocol, 99‑metastable technetium nanocolloid intradermal injection
at the first interdigital space, were analyzed quantitatively. Fifty‑three normal and 51 abnormal limbs were analyzed. For each limb, a region of
interest (ROI) was drawn around the injection site, and ilioinguinal nodes on the 1.5 h static images and the counts in these ROIs were recorded.
Percentage ilioinguinal nodes uptake was then computed. Analysis of variance (ANOVA) was performed to determine the difference in ilioinguinal
uptake between normal and abnormal limbs. Specificity and sensitivity were calculated and the figures were used to plot a receiver operator
characteristic (ROC) curve. Thirty‑six females and 16 males (104 limbs) were analyzed. ANOVA revealed a significant difference between the
mean uptake in normal (19.7%) and abnormal limbs (5.5%) (F = 81, P < 0.001). ROC had a maximal area under the curve of 0.924 (P < 0.001).
The significant difference in the means of ilioinguinal uptake between normal and lymphedema limbs infers reduced lymphatic function. Ilioinguinal
lymph node uptake is thus a reliable parameter in quantitative analysis of lymphoscintigrams.
Keywords: Lymphedema, lymphoscintigraphy, nuclear medicine, qualitative analysis, quantitative analysis

INTRODUCTION
Lymphedema is a painless, progressive accumulation of
protein‑rich fluid in the interstitial spaces of the skin,
resulting from an anatomic or functional obstruction of the
lymphatic system.[1,2] It is most common in the lower limbs,
about 80% of cases, but can also occur in the arms, trunk,
and external genitalia.
The primary pathology leading to lymphedema is dysfunction
of the lymphatic transportation system.[3] Disruption of
the lymphatic systems by pathological processes such
as trauma, surgery and radiotherapy, infection, and
congenital abnormalities can lead to lymphedema. [4]
Primary lymphedema is usually as a result of congenital
abnormalities in the lymphatic system which can be either
aplasia or hypoplasia.[5,6] Lymphedema praecox is early‑onset
lymphedema, typically before 35 years. It is characterized
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by hypoplastic lymphatic system and is usually unilateral.
Lymphedema tarda usually presents after 35 years of age, and
there is much debate regarding its etiology. Milroy disease is
the autosomal dominant form of typically bilateral primary
lymphedema with the very early age of onset and is due to
agenesis of the lymphatic system.[7]
Secondary lymphedema results from obstruction or
interruption of the normal lymphatic channels. This can be
iatrogenic (surgery and/or radiotherapy) or due to trauma or
infections such as filariasis.[8]
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Figure 1: 1.5‑h images of normal (a and b) and abnormal (c and d)
lymphoscintigrams. 1.5‑h images of normal (a and b) and abnormal (c and d)
lymphoscintigrams. (a and b), There is fairly uniform migration of tracer
to the ilioinguinal lymph nodes. (c) There is dermal backflow in the left
lower limb, due to interruption of the lymphatic channels, and although
not readily apparent, slightly less tracer reaches the left ilioinguinal nodes
compared to the right; hence quantitative analysis would be of value in this
case. (d) There is congenital aplasia of the lymphatic channels on the right
and no tracer reaches the ilioinguinal nodes

Figure 3: Bar graph showing distribution of lymphedema by sex and side

Lymphoscintigraphy is the primary imaging modality used in
determining a diagnosis in patients with suspected extremity
lymphedema.[5,6,9] The current protocol in our institution
utilizes 20–40 mega‑Becquerels (MBq) of 99‑metastable
technetium (Tc‑99m) nanocolloid, injected intradermally, with
static image acquisition at 5‑min, 15‑min, and 1.5‑h intervals.
Field of view is at the injection site on 5‑min images and from
the feet to the pelvis for the 15 minutes and 1.5 hour images.
The patients walk for at least 5 min before the 15‑min image.

Figure 2: Lymphoscintigraphy image showing the regions of interest drawn
around the injection site (A) and ilioinguinal nodes (B) for computation of
ilioinguinal uptake

Quantitative and semiquantitative analysis parameters can
be used to complement visual analysis, to better characterize
discrete changes, or to monitor therapeutic assessment in
sequential studies.[10]
Quantitative parameters that can be assessed include the
clearance of activity from the injection site, the fraction of
the injected dose that accumulates in the draining lymph
node groups, and the appearance of the radioactivity in the
liver or blood.[3,11]
Quantitative analysis provides a means to unif y the
interpretation of scintigraphic findings, allowing for

Figure 4: Bar and whisker plot of uptake in lymphedema limbs and normal
limbs

the detection of small changes in lymphatic function.
Furthermore, the quantitative analysis can facilitate the
comparison between studies during follow‑up or after
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Figure 5: Histograms showing distribution of percentage lymph node uptake

Figure 6: Q–Q plots showing distribution of ilioinguinal uptake in normal limbs and lymphedema limbs

therapeutic interventions in a patient. Analysis by less
experienced radiologists and nuclear physicians can be
enhanced by quantitative analysis.
The data obtained would provide a more sensitive and
reproducible approach to differentiate normal patients
from those with mild lymphedema, more so for the less
experienced radiologist.

N=

4σ 2 ( Z crit + Z pwr )
D2

The study had a power of 80% and with 0.05 margin of error.
The estimated sample size was 102, 51 for the group with
lymphedema and 51 for the group with normal limbs.

Patients without images at 1.5 h were excluded from the
study.

Patients were positioned supine and the Tc‑99m nanocolloid
was injected intradermally to the first interdigital web of
both limbs – if the dose was uneven, the larger dose was
administered to the affected or more edematous limb.
A static planar image of the feet with the entire injection
site in the field of view was obtained 5‑min postinjection,
on a 256 × 256 matrix. The patients were then asked to
walk up and down the hallway 4–5 times (at least 2 min)
and return back for 15‑min delay images. A hemi‑body
planar image (starting from hip to feet) was obtained at
15‑min and 1.5‑h postinjection, using a 256 × 1024 matrix.

The sample size was calculated using the formula for studies
comparing two means; the equation used for the sample size
calculation is as follows:

Normal or abnormal limbs were selected on the basis
of qualitative analysis by a consultant nuclear medicine
physician with a 15‑year experience. Normal limbs showed

MATERIALS AND METHODS
This was a prospective cross‑sectional study, in which
consecutive patients undergoing lymphoscintigraphy at the
Nuclear Medicine Department for suspected lymphedema, on
the basis of unexplained lower‑limb swelling, were recruited.
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Table 1: Demographic characteristics of the subjects
Age of subject
(years)
Age at onset of
edema (years)
Duration of
edema (years)

n

Minimum

Maximum

Mean

Median

SD

52

3

90

37.9

37.5

19.7

52

0

70.0

32.3

30

17.1

52

0

30

5.5

3

7.0

SD: Standard deviation

Table 2: Distribution of lymphedema by sex
Sex

Outcome (/limb)
Lymphedema
Normal

Male
Female
Total

25
26
51

Total

7
46
53

32
72
104

Figure 7: Receiver operator characteristic curve

All statistical analysis was performed using SPSS version 17
(SPSS Statistics for Windows, SPSS Inc: Chicago, USA).

Table 3: Ilioinguinal lymph node uptake among normal and
lymphedema limbs
Outcome

n

Mean (%)

SD

SEM

Ilioinguinal node uptake
Lymphedema
Normal

51
53

5.5
19.7

4.8
10.2

0.7
1.4

SD: Standard deviation; SEM: Standard error of mean

prompt and uniform migration of the radionuclide through
discrete lymph vessels. Abnormal limbs had a combination
of any of the following findings: interruption of lymphatic
flow, collateral lymph vessels, progressive dermal backflow,
delayed flow, delayed visualization or nonvisualization of
lymph nodes, reduced number of lymph nodes, dilated
lymphatics, and in severe cases no visualization of the
lymphatic system at all [Figure 1].
For all the normal limbs, a region of interest was drawn
around the injection site (B) and inguinal nodes (A) at 1.5‑h
static images [Figure 2]. Inguinal node uptake was computed
as follows:
A
×100
( A + B)
A similar analysis was done for the abnormal limbs.
Approval for the study was obtained from the institutional
ethics review committee. All the study participants gave
written informed consent. Consent was obtained from
all the adult study participants and from the guardians of
participants aged below 18 years.
This study portends no harm to the participants, and the
standard imaging protocol was not altered. The study
investigators have no conflict of interest to declare.

RESULTS
Fifty‑five bilateral lymphoscintigraphic examinations
were performed between August 2014 and January 2015.
Fifty‑two patients (25 males and 26 females) were included
in the final study. Excluded patients included one where
1.5‑h images were not acquired and two patients in whom
both injection sites and ilioinguinal nodes were not in the
field of view on the 1.5‑h images. The median age was
37.5 years, with a standard deviation (SD) of 19.7; their mean
duration of lymphedema was at least 5.5 years [Table 1].
The proportion of males with positive scans (diagnosis of
lymphedema) was significantly higher (78% vs. 36% P < 0.001).
Both limbs were equally affected with lymphedema, with no
preference for either side [Figure 3 and Table 2].
Quantitative analysis
The mean for each of the groups is illustrated in [Table 3
and Figure 4].
The data were skewed to the right in both the normal group
and the group with lymphedema [Figure 5]. The Kolmogorov–
Smirnov test for normality, however, showed a lognormal
distribution which is a common finding in many biologic
samples [Figure 6].
Analysis of variance
Following analysis of variance (ANOVA), the difference
of the means between the two groups was statistically
significant (P ≤ 0.0001). An F value (a measure of
intergroup vs. intragroup variance) of 81.37 indicates a
large difference.
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Receiver operator characteristics
Using different cutoffs of percentage ilioinguinal uptake,
specificity and sensitivity were calculated, and the
values obtained were used to plot a receiver operator
characteristic (ROC) curve [Figure 7]. Area under the
curve (AUC) was also estimated. AUC was 0.924.
The cutoff value giving the best trade‑ off between
sensitivity and specificity (highest and most to the left) is
9.74 (sensitivity = 86.8%, specificity = 82.4%).
DISCUSSION
The study sample consisted of 36 females and 16 males. The
mean age of the population was 37.9 years, with a range from
3 to 90 years. It was noted that most patients presented in
their 30s to 40s, which perhaps represents patients with
lymphedema tarda.
Secondary lower‑limb lymphedema is not common in our
setting. This is in sharp contrast to studies in Europe and
Asia where secondary causes predominate.
The average onset of lymphedema was 32 years. This could
be partly explained by lymphedema tarda which prior authors
have given as onset of lymphedema after 35 years.[12] The
patients whose onset of edema was between puberty and
30 years represent patients with lymphedema praecox.
A small number of patients with congenital lymphedema
presented before puberty.
The average duration of edema at the time of presentation
was 5.4 years (0–30 years). The fact that most patients
sought intervention after a mean duration of 5 years may
reflect onset of other clinical symptoms besides edema or
worsening edema.
Following qualitative lymphoscintigraphy, only one male
patient had a normal examination while the rest had either
unilateral (5 subjects) or bilateral lymphedema (10 subjects).
In contrast, 16 females had normal limbs, while 14 had
unilateral lymphedema and six had bilateral lymphedema.
The proportion of males with positive scans was significantly
higher (78% vs. 36% P = 0.000). This suggests that edema of
whatever etiology may be more common in females, while
edema in males is more likely to be lymphedema. Most other
studies have indicated a higher incidence of lymphedema
among females. Indeed, some causes of lower‑limb swelling
such as lipedema are exclusive to women.[13] Obesity which is
a recognized risk factor for lymphedema[14] is more common
in females. In a study by Dalia et al., a total of 77 patients
(66 women, 11 men) were studied.[15] Of these, 21 patients
40

had unilateral extremity involvement and 56 had bilateral
lymphedema. It seems that unilateral lymphedema is more
common in our population.
Among the patients with unilateral edema, there was a
trend toward more involvement of the left limb. The level
of physical activity aids in lymphatic clearance, and most
people in the general population are right‑handed, which
may partially explain the higher number of abnormal left
limbs, but this may be further investigated with more robust
research. On quantitative analysis of ilioinguinal lymph node
uptake, the limbs with lymphedema had reduced uptake:
mean 5.5, SD 4.8. Normal limbs had significantly higher
ilioinguinal uptake values and a large SD of 10.1. A statistically
significant difference between the means of the two groups
was observed after ANOVA. F statistic of 81 indicates a large
difference between the two means. The data described in
this study are compatible with that in the literature, showing
reduced ilioinguinal lymph node accumulation of radiotracer
in lymphedema.[15,16]
Using qualitative lymphoscintigraphy as the reference
standard, sensitivity and specificity for each ilioinguinal
uptake value were computed and an ROC curve was
plotted. The AUC was 0.924 (P < 0.001). This indicates that
quantitative analysis is an accurate tool in the diagnosis of
lymphedema.
By selecting an ilioinguinal node uptake of 9.7%, lymphedema
could be diagnosed with 86.8% sensitivity and 82.4% specificity.
When lymphatic dysfunction is bilateral, quantification of
lymph node accumulation and clearance of activity from
the injection site both become important parameters.
Again, it should be emphasized that these parameters are
strongly influenced by the amount of exercise a patient
can perform.[17] In addition, the uptake index can be used
to monitor progression of disease as well as response to
therapeutic measures.
CONCLUSION
Ilioinguinal lymph node uptake can be used for the
differentiation of normal limbs from limbs with
lymphedema. Quantitative analysis if developed and
standardized can be an accurate tool in the diagnosis
of lymphedema. Quantitative indices would be useful
for monitoring of disease progression and efficacy of
therapeutic measures.
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